PT MITRA KELUARGA KARYASEHAT TBK |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,850 IDR | -3.39% |
|
+6.34% | 0.00% |
| Sales 2024 * | 4,820B 299M | Sales 2025 * | 5,434B 337M | Capitalization | 39,636B 2.46B |
|---|---|---|---|---|---|
| Net income 2024 * | 1,103B 68.39M | Net income 2025 * | 1,296B 80.35M | EV / Sales 2024 * | 8.08 x |
| Net cash position 2024 * | 698B 43.27M | Net cash position 2025 * | 1,090B 67.55M | EV / Sales 2025 * | 7.09 x |
| P/E ratio 2024 * |
36.5
x | P/E ratio 2025 * |
31.4
x | Employees | 8,803 |
| Yield 2024 * |
1.67% | Yield 2025 * |
1.45% | Free-Float | 34.2% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -3.39% | ||
| 1 week | +6.34% | ||
| Current month | +4.01% | ||
| 1 month | +4.40% | ||
| 3 months | +10.04% | ||
| 6 months | +1.79% |
1 week
2 670.00
3 030.00
1 month
2 600.003 030.00
Current year
2 490.003 030.00
1 year
2 430.003 100.00
3 years
2 080.003 400.00
5 years
1 570.003 400.00
10 years
1 370.003 400.00
| Managers | Title | Age | Since |
|---|---|---|---|
Rustiyan Oen
CEO | Chief Executive Officer | 62 | 96-12-31 |
Berry Karlis
DFI | Director of Finance/CFO | - | - |
| Investor Relations Contact | 53 | 13-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 79 | 20-06-23 | |
| Chairman | 56 | 13-12-31 | |
I. Gede Subawa
BRD | Director/Board Member | 73 | 14-11-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.63% | 9 M€ | -3.31% | - | |
| 0.93% | 2 M€ | -14.14% | ||
| 0.01% | 117 M€ | +1.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 2,850 | -3.39% | 11,414,100 |
| 24-04-25 | 2,950 | +7.66% | 21,818,100 |
| 24-04-24 | 2,740 | +1.86% | 8,772,700 |
| 24-04-23 | 2,690 | +0.37% | 5,914,300 |
| 24-04-22 | 2,680 | 0.00% | 9,440,400 |
End-of-day quote INDONESIA S.E., April 25, 2024
More quotes
PT Mitra Keluarga Karyasehat Tbk is an Indonesia-based company, which is focused on providing healthcare services to patients under the Governmentâs Health Insurance Scheme, Jaminan Kesehatan Nasional (JKN). The Company serves Indonesiaâs private insurance patients and corporate clients, to out-of-pocket expense individual patients to JKN member patients. The Company operates through two segments: Outpatient and Inpatient. The Company provides outpatient and inpatient healthcare services to all market groups, including private insurance patients and corporate clients, to out-of-pocket expense individual patients and JKN member patients. The Companyâs subsidiaries include PT Proteindo Karyasehat (PKS), PT Ekamita Arahtegar (EAT), PT Ragamsehat Multifita (RSM), PT Alpen Agung Raya (AAR), PT Rumah Kasih Indonesia (RKI), PT Bina Husada Gemilang (BHG), PT Kinarya Loka Buana (KLB), and PT Sehat Digital Nusantara (SDN).
Calendar
2024-07-30
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
2,850
IDR
Average target price
3,052
IDR
Spread / Average Target
+7.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 2.53B | |
| -20.16% | 15.76B | |
| +4.50% | 12.34B | |
| +3.98% | 11.52B | |
| +9.72% | 11.02B | |
| +23.61% | 8.28B | |
| -2.19% | 7.8B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.64B |
- Stock Market
- Equities
- MIKA Stock
